Item 2.02. Results of Operations and Financial Conditions.

On November 5, 2012, Pharmacyclics, Inc., a Delaware corporation (the "Registrant"), issued a press release regarding its financial results for its first fiscal quarter ended September 30, 2012. A copy of the press release is attached as Exhibit 99.1.

The foregoing description is qualified in its entirety by reference to the Registrant's Press Release dated November 5, 2012, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities thereof, nor shall it be deemed to be incorporated by reference into future filings by the Company under the Exchange Act or under the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press Release dated November 5, 2012.

---